Today's Datapoint
11% is the annual rate of
growth projected through 2020 for the sale of orphan drugs in the U.S.,
compared to approximately 4% for drugs that treat larger populations, according
to the EvaluatePharma Orphan Drug Report 2014, from Evaluate Ltd.
No comments:
Post a Comment